KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals has informed BSE that the trading window for its equity shares will be closed from Wednesday, October 1, 2025, until 48 hours after the declaration of unaudited financial results for the quarter and half year ended September 30, 2025. All designated persons and their immediate relatives are barred from buying, selling, or otherwise dealing in the company's shares during this blackout period. The move is in compliance with SEBI's Insider Trading Regulations and the company's internal code of conduct. The date of the board meeting to approve the Q2/H1 results will be announced separately. The intimation was signed by Managing Director Ramesh Arora.
This is a routine regulatory filing ahead of the upcoming quarterly results — it carries no positive or negative signal on its own, but tells investors that the company's Q2 FY26 earnings are due soon and that insiders are restricted from trading until after the announcement.